FDA Inspection 806119 — Dermazone LLC

Dermazone LLC — FEI 1000113908

The FDA completed an inspection of Dermazone LLC on November 1, 2012 in Saint Petersburg, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 1, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Petersburg, FL (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
138421 CFR 211.101(c)Weighing/measuring/subdividing supervision
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
202721 CFR 211.192Investigations of discrepancies, failures
219621 CFR 211.186(b)(1)Product Name and Strength
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
437221 CFR 211.188(b)(8)Labeling control records including specimens or copies
437421 CFR 211.188(b)(6)Inspection of packaging and labeling area